110
Participants
Start Date
June 9, 2020
Primary Completion Date
April 20, 2022
Study Completion Date
May 10, 2022
Nifedipine 30 MG
Nifedipine XL is a long-acting medication used to lower blood pressure. The investigators want to learn whether women who receive the study drug will experience fewer severe-range blood pressure readings, and therefore need fewer intravenous (IV) medications to safely lower blood pressure.
Placebos
At the time of enrollment, patients will be randomized to either the study drug (oral Nifedipine XL 30mg) or identical placebo.
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
Ohio State University
OTHER